Lisata Therapeutics Stock Investor Sentiment

LSTA Stock  USD 2.26  0.07  3.00%   
About 61% of Lisata Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Lisata Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Lisata Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Lisata Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
over a week ago at gurufocus.com         
10x Genomics Secures Injunction Against Parse Biosciences Planned ATAC Products
Gurufocus Stories at Macroaxis
over a week ago at simplywall.st         
Shenzhen Chipscreen Biosciences Full Year 2024 Earnings Misses Expectations
Simply Wall St News at Macroaxis
over a week ago at thelincolnianonline.com         
Arcus Biosciences, Inc. Director Purchases 201,200.00 in Stock
news
over a week ago at finance.yahoo.com         
Avidity Biosciences Full Year 2024 Earnings Revenues Beat Expectations, EPS In Line
Yahoo News
over a week ago at thelincolnianonline.com         
Aptose Biosciences Upgraded to Strong-Buy at Alliance Global Partners
news
over a week ago at gurufocus.com         
Lisata Therapeutics Inc Q4 2024 Earnings Call Highlights Promising Developments Amid ...
Gurufocus Stories at Macroaxis
over a week ago at simplywall.st         
Neurocrine Biosciences Highlights INGREZZAs Positive Phase 4 Study Results
Simply Wall St News at Macroaxis
over a week ago at insidermonkey.com         
Lisata Therapeutics, Inc. Q4 2024 Earnings Call Transcript
insidermonkey News
over a week ago at prnewswire.com         
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635
prnewswire News
over a week ago at gurufocus.com         
Avidity Biosciences Reports Fourth Quarter 2024 Financial Results and Recent Highlights
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Cytek Biosciences, Inc. Tops Q4 Earnings Estimates
Yahoo News
over a week ago at gurufocus.com         
Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
Gurufocus Stories at Macroaxis
over a week ago at zacks.com         
Cytek Biosciences, Inc. Tops Q4 Earnings Estimates
zacks News
over two weeks ago at simplywall.st         
While LigaChem Biosciences shareholders have made 380 percent in 5 years, increasing losses might no...
Simply Wall St News at Macroaxis
over two weeks ago at finance.yahoo.com         
Should Value Investors Buy Harmony Biosciences Stock?
Yahoo News
Far too much social signal, news, headlines, and media speculation about Lisata Therapeutics that are available to investors today. That information is available publicly through Lisata media outlets and privately through word of mouth or via Lisata internal channels. However, regardless of the origin, that massive amount of Lisata data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Lisata Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Lisata Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Lisata Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Lisata Therapeutics alpha.

Lisata Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Lisata Stock analysis

When running Lisata Therapeutics' price analysis, check to measure Lisata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lisata Therapeutics is operating at the current time. Most of Lisata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lisata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lisata Therapeutics' price. Additionally, you may evaluate how the addition of Lisata Therapeutics to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
CEOs Directory
Screen CEOs from public companies around the world